Europe Biosensors Market Size & Outlook, 2026-2033
The biosensors market in Europe is expected to reach a projected revenue of US$ 18,534.1 million by 2033. A compound annual growth rate of 9.46% is expected of Europe biosensors market from 2026 to 2033.
The Europe biosensors market generated a revenue of USD 9,103.8 million in 2025.
The market is expected to grow at a CAGR of 9.46% from 2026 to 2033.
In terms of segment, electrochemical was the largest revenue generating technology in 2025.
Electrochemical is the most lucrative technology segment registering the fastest growth during the forecast period.
Country-wise, UK is expected to register the highest CAGR from 2026 to 2033.
Europe data book summary
Market revenue in 2025
USD 9,103.8 million
Market revenue in 2033
USD 18,534.1 million
Growth rate
9.46% (CAGR from 2026 to 2033)
Largest segment
Electrochemical
Fastest growing segment
Electrochemical
Historical data covered
2021 - 2024
Base year for estimation
2025
Forecast period covered
2026 - 2033
Quantitative units
Revenue in USD million
Market segmentation
Thermal, Electrochemical, Piezoeletric, Optical
Key market players worldwide
Bio-Rad Laboratories Inc, Medtronic PLC, Abbott Laboratories, Biosensors, Pinnacle Financial Partners Inc, DuPont Nutrition & Biosciences, Johnson & Johnson, Koninklijke Philips NV, Nova Biomedical, Koch Industries, TDK Corp, Siemens AG
Other key industry trends
In terms of revenue, Europe region accounted for 28.3% of the global biosensors market in 2025.
Globally, North America is projected to lead the regional market in terms of revenue in 2033.
Asia Pacific is the fastest growing regional market and is projected to reach USD 14,226.6 million by 2033.
Increasing geriatric population and rising prevalence of chronic diseases in the region are some of the major drivers of the market. In addition, increasing acceptance of POC diagnostic kits and government contracts contributing toward the development of PoC diagnostic equipment are expected to fuel the market growth. Furthermore, presence of favorable government initiatives and rapid development of independent diagnostic centers are anticipated to propel the market growth over the forecast period.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biosensors Market Outlook will help companies and investors design strategic landscapes.
Electrochemical was the largest segment with a revenue share of 76.88% in 2025.
Horizon Databook has segmented the Europe biosensors market based on thermal, electrochemical, piezoeletric, optical covering the revenue growth of each sub-segment from 2021 to 2033.
Increasing geriatric population and rising prevalence of chronic diseases in the region are some of the major drivers of the market. In addition, increasing acceptance of POC diagnostic kits and government contracts contributing toward the development of PoC diagnostic equipment are expected to fuel the market growth. Furthermore, presence of favorable government initiatives and rapid development of independent diagnostic centers are anticipated to propel the market growth over the forecast period.
Europe Biosensors Market Technology Outlook (Revenue, USD Million , 2021-2033)
Thermal
Electrochemical
Piezoeletric
Optical
Europe Biosensors Market Application Outlook (Revenue, USD Million , 2021-2033)
Medical
Food Toxicity
Bioreactor
Agriculture
Environment
Others
Europe Biosensors Market End Use Outlook (Revenue, USD Million , 2021-2033)
Home healthcare diagnostics
PoC testing
Food industry
Research Laboratories
Security and Bio-defense
Reasons to subscribe to Biosensors Market Outlook databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biosensors Market Outlook databook
Our clientele includes a mix of Biosensors Market Outlook companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe Biosensors Market Outlook, including forecasts for subscribers. This continent databook contains high-level insights into Europe Biosensors Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.